Tred Avon Family Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
55,969
+5,402
+11% +$144K 0.52% 45
2025
Q4
$1.26M Sell
50,567
-5,167
-9% -$130K 0.41% 61
2025
Q3
$1.42M Buy
+55,734
New +$1.38M 0.49% 49

Other funds holding PFE

Tred Avon Family Wealth's PFE Position: Q1 2026 in Review

Tred Avon Family Wealth increased its Pfizer (PFE) stake by 11% in Q1 2026, buying an estimated $144K and bringing the position to 55,969 shares worth $1.57M. The position accounts for 0.52% of the portfolio, ranked #45.

Tred Avon Family Wealth first reported a position in PFE in Q3 2025 and has held it in 3 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Tred Avon Family Wealth held 55,969 shares of Pfizer worth $1.57M as of Q1 2026.
  • Tred Avon Family Wealth bought 5,402 Pfizer shares in Q1 2026, an estimated $144K.
  • Pfizer made up 0.52% of Tred Avon Family Wealth's portfolio in Q1 2026, its #45 holding.
  • Tred Avon Family Wealth first reported a position in Pfizer in Q3 2025 and has held it in 3 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Tred Avon Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.